Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 9/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | CACNA1F | O60840 | 3/20 | 0.39 |
| ▸ | CACNA1D | Q01668 | 3/20 | 0.39 |
| ▸ | CACNA1S | Q13698 | 3/20 | 0.39 |
| ▸ | CACNA1C | Q13936 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 2/20 | 0.36 |
| ▸ | TMPRSS6 | Q8IU80 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10471403 | 0.77 | SLC1A1 (0.41) | TACR1SLC1A1CACNA1FCACNA1DCACNA1S | |
| SCHEMBL16103748 | 0.72 | SLC1A1 (0.54) | TACR1SLC1A1CA1CA2CA7 | |
| SCHEMBL10098451 | 0.72 | SLC1A1 (0.54) | TACR1SLC1A1CA1CA2CA7 | |
| SCHEMBL10098462 | 0.71 | SLC1A1 (0.52) | TACR1SLC1A1CA1CA2CA7 | |
| SCHEMBL16103417 | 0.71 | SLC1A1 (0.52) | TACR1SLC1A1CA1CA2CA7 | |
| Trifluoroacetic Acid SCHEMBL30950059 | 0.70 | SLC1A1 (0.46) | TACR1SLC1A1CA1F2TMPRSS6 | |
| Trifluoroacetic Acid SCHEMBL23390351 | 0.70 | SLC1A1 (0.51) | TACR1SLC1A1CA1CES1F2 | |
| Trifluoroacetic Acid SCHEMBL3580103 | 0.70 | SLC1A1 (0.62) | TACR1SLC1A1CA1CES1F2 | |
| Trifluoroacetic Acid SCHEMBL23390354 | 0.70 | SLC1A1 (0.51) | TACR1SLC1A1CA1CES1F2 | |
| SCHEMBL18394417 | 0.69 | TACR1 (0.63) | TACR1SLC1A1CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | TACR1 19/4885SLC1A1 465/4885CACNA1F 1946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.